Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640653 · ClinicalTrials.gov registry record · NA
Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 662
- Enrollment target
NCT00640653: Completed NA study, sponsored by University of Pennsylvania.
NCT00640653 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 662 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00640653, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 662 participants
- Enrollment target
Study Summary
This study will develop and evaluate the effectiveness of culturally appropriate HIV/sexually transmitted disease risk-reduction interventions in reducing sexual risk behavior among young African-American adolescents.
Primary Outcome
Self-reported sexual initiation during the follow-up period among participants who reported never having sexual intercourse at baseline.
Interventions
- BEHAVIORAL Abstinence-only HIV/STD risk-reduction intervention
- BEHAVIORAL Safer-sex-only HIV/STD risk-reduction intervention
- BEHAVIORAL Long comprehensive HIV/STD risk-reduction intervention
- BEHAVIORAL Short comprehensive HIV/STD risk-reduction intervention
- BEHAVIORAL Health promotion control intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 662 participants |
| Start Date | 2001-09 |
| Est. Completion | 2004-08 |
| Phase | NA |
What the finished NCT00640653 record still lists
NCT00640653 is an interventional study that assigns participants to a tested intervention. The registered 662 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 5 interventions - of which Abstinence-only HIV/STD risk-reduction intervention is the first listed.
NCT00640653 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00640653 about?
NCT00640653 is a clinical study titled "Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents". This study will develop and evaluate the effectiveness of culturally appropriate HIV/sexually transmitted disease risk-reduction interventions in reducing sexual risk behavior among young African-American adolescents.
What is the current status of trial NCT00640653?
This trial is currently completed. It is a NA study. The enrollment target is 662 participants. The study started on 2001-09. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00640653?
The interventions under investigation include: Abstinence-only HIV/STD risk-reduction intervention (BEHAVIORAL), Safer-sex-only HIV/STD risk-reduction intervention (BEHAVIORAL), Long comprehensive HIV/STD risk-reduction intervention (BEHAVIORAL), Short comprehensive HIV/STD risk-reduction intervention (BEHAVIORAL), Health promotion control intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00640653?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00640653's enrollment target sits among peer trials
662 155th of 2000 higher than 1,846 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05254743 · 662 participants · Phase 3
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- NCT07164443 · 663 participants · Phase 3
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NCT06607341 · 664 participants · NA
Community Engagement Alliance Against Disparities
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia